Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - ScienceDirect
Cancers | Free Full-Text | Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
![Classification of HER2 status according to the ASCO/CAP Guideline 2023 [5]. | Download Scientific Diagram](https://www.researchgate.net/publication/373881195/figure/tbl1/AS:11431281188427176@1694610523638/Classification-of-HER2-status-according-to-the-ASCO-CAP-Guideline-2023-5.png "Classification of HER2 status according to the ASCO/CAP Guideline 2023 [5]. | Download Scientific Diagram")
Classification of HER2 status according to the ASCO/CAP Guideline 2023 [5]. | Download Scientific Diagram
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/ CAP ISH group 4 breast cancer | npj Breast Cancer
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer - Vermij - 2021 - Histopathology - Wiley Online Library
HER2 Testing in Breast Cancer Guidelines Pocket Guide - Guideline Central
Applying the 2023 ASCO-CAP guideline updates for HER2 testing in breast cancer
Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry | Virchows Archiv
Selecting patients with HER2-low breast cancer: Getting out of the tangle - European Journal of Cancer
What is HER2 positive breast cancer in 2018? Updated ASCO-CAP guidelines
HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
status of her2 testing* before and after the establishment of asCO/CaP... | Download Table
ASCO-CAP HER2 Test Guideline Recommendations PDF | PDF | Immunohistochemistry | Metastasis
![PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d99c6aa1dcc660fbabc1af5e20d607b8747a33a1/3-Figure1-1.png "PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar")
PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar
![PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical](https://d3i71xaburhd42.cloudfront.net/c7289407931d6ff274350f21b4024900edadc66e/2-Figure1-1.png "PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical")
PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update | Journal of Clinical Oncology
Q&A column - CAP TODAY
Scoring HER2 expression across the full spectrum - CAP TODAY
Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort - ScienceDirect
HER2 IHC and Her2 FISH Criteria Under the 2007 and the 2013 ASCO/CAP... | Download Table
